Cornerstone Advisory’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $751K | Buy |
2,073
+60
| +3% | +$20.5K | 0.06% | 136 |
|
|
2026
Q1 | $708K | Buy |
2,013
+61
| +3% | +$21.7K | 0.07% | 126 |
|
|
2025
Q4 | $639K | Sell |
1,952
-475
| -20% | -$151K | 0.06% | 138 |
|
|
2025
Q3 | $685K | Buy |
2,427
+6
| +0.2% | +$1.74K | 0.07% | 124 |
|
|
2025
Q2 | $676K | Sell |
2,421
-316
| -12% | -$89.5K | 0.07% | 126 |
|
|
2025
Q1 | $740K | Buy |
2,737
+153
| +6% | +$45.2K | 0.09% | 113 |
|
|
2024
Q4 | $752K | Buy |
2,584
+92
| +4% | +$27.3K | 0.09% | 107 |
|
|
2024
Q3 | $803K | Buy |
2,492
+16
| +0.6% | +$5.23K | 0.11% | 97 |
|
|
2024
Q2 | $773K | Buy |
2,476
+8
| +0.3% | +$2.35K | 0.11% | 88 |
|
|
2024
Q1 | $702K | Sell |
2,468
-36
| -1% | -$10.5K | 0.1% | 114 |
|
|
2023
Q4 | $721K | Buy |
2,504
+99
| +4% | +$27K | 0.11% | 110 |
|
|
2023
Q3 | $646K | Buy |
2,405
+27
| +1% | +$6.74K | 0.11% | 108 |
|
|
2023
Q2 | $528K | Buy |
2,378
+22
| +0.9% | +$5.11K | 0.09% | 129 |
|
|
2023
Q1 | $569K | Buy |
2,356
+30
| +1% | +$7.36K | 0.1% | 121 |
|
|
2022
Q4 | $611K | Buy |
2,326
+6
| +0.3% | +$1.61K | 0.12% | 112 |
|
|
2022
Q3 | $523K | Hold |
2,320
| – | – | 0.12% | 115 |
|
|
2022
Q2 | $565K | Hold |
2,320
| – | – | 0.13% | 109 |
|
|
2022
Q1 | $561K | Sell |
2,320
-779
| -25% | -$179K | 0.09% | 158 |
|
|
2021
Q4 | $698K | Buy |
3,099
+1,282
| +71% | +$271K | 0.1% | 151 |
|
|
2021
Q3 | $387K | Buy |
1,817
+1
| +0.1% | +$230 | 0.06% | 177 |
|
|
2021
Q2 | $443K | Sell |
1,816
-7
| -0.4% | -$1.72K | 0.07% | 164 |
|
|
2021
Q1 | $454K | Sell |
1,823
-1,605
| -47% | -$383K | 0.09% | 159 |
|
|
2020
Q4 | $788K | Buy |
3,428
+228
| +7% | +$52.6K | 0.16% | 111 |
|
|
2020
Q3 | $813K | Buy |
3,200
+300
| +10% | +$74.3K | 0.19% | 96 |
|
|
2020
Q2 | $684K | Buy |
2,900
+1,454
| +101% | +$332K | 0.18% | 93 |
|
|
2020
Q1 | $293K | Sell |
1,446
-400
| -22% | -$87.4K | 0.09% | 128 |
|
|
2019
Q4 | $445K | Sell |
1,846
-7
| -0.4% | -$1.54K | 0.09% | 120 |
|
|
2019
Q3 | $359K | Hold |
1,853
| – | – | 0.08% | 124 |
|
|
2019
Q2 | $342K | Sell |
1,853
-300
| -14% | -$53.7K | 0.07% | 129 |
|
|
2019
Q1 | $409K | Sell |
2,153
-80
| -4% | -$15.3K | 0.09% | 112 |
|
|
2018
Q4 | $435K | Buy |
2,233
+7
| +0.3% | +$1.37K | 0.11% | 102 |
|
|
2018
Q3 | $462K | Sell |
2,226
-8
| -0.4% | -$1.58K | 0.14% | 99 |
|
|
2018
Q2 | $412K | Buy |
2,234
+25
| +1% | +$4.42K | 0.14% | 103 |
|
|
2018
Q1 | $377K | Sell |
2,209
-58
| -3% | -$10.6K | 0.14% | 105 |
|
|
2017
Q4 | $394K | Buy |
2,267
+7
| +0.3% | +$1.24K | 0.14% | 106 |
|
|
2017
Q3 | $422K | Sell |
2,260
-4
| -0.2% | -$709 | 0.14% | 103 |
|
|
2017
Q2 | $390K | Buy |
2,264
+165
| +8% | +$26.8K | 0.13% | 102 |
|
|
2017
Q1 | $344K | Buy |
2,099
+2
| +0.1% | +$332 | 0.17% | 79 |
|
|
2016
Q4 | $307K | Sell |
2,097
-1,209
| -37% | -$182K | 0.23% | 65 |
|
|
2016
Q3 | $552K | Sell |
3,306
-183
| -5% | -$30.9K | 0.45% | 37 |
|
|
2016
Q2 | $531K | Buy |
3,489
+3
| +0.1% | +$466 | 0.45% | 37 |
|
|
2016
Q1 | $523K | Sell |
3,486
-131
| -4% | -$19.5K | 0.45% | 36 |
|
|
2015
Q4 | $587K | Buy |
+3,617
| New | +$569K | 0.51% | 34 |
|
Other funds holding AMGN
FFM
SP
Cornerstone Advisory's AMGN Position: Q2 2026 in Review
Cornerstone Advisory increased its Amgen (AMGN) stake by 3% in Q2 2026, buying an estimated $20.5K and bringing the position to 2,073 shares worth $751K. The position accounts for 0.06% of the portfolio, ranked #136.
Cornerstone Advisory first reported a position in AMGN in Q4 2015 and has held it in 43 quarters since. The position peaked at $813K in Q3 2020. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Cornerstone Advisory held 2,073 shares of Amgen worth $751K as of Q2 2026.
- Cornerstone Advisory bought 60 Amgen shares in Q2 2026, an estimated $20.5K.
- Amgen made up 0.06% of Cornerstone Advisory's portfolio in Q2 2026, its #136 holding.
- Cornerstone Advisory first reported a position in Amgen in Q4 2015 and has held it in 43 quarters since.
- Cornerstone Advisory's Amgen position peaked at $813K in Q3 2020.
- 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Cornerstone Advisory's 13F filing for Q2 2026, filed 29 Jul 2026.